全文获取类型
收费全文 | 941篇 |
免费 | 64篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 13篇 |
妇产科学 | 16篇 |
基础医学 | 130篇 |
口腔科学 | 5篇 |
临床医学 | 109篇 |
内科学 | 259篇 |
皮肤病学 | 13篇 |
神经病学 | 72篇 |
特种医学 | 23篇 |
外科学 | 110篇 |
综合类 | 7篇 |
预防医学 | 65篇 |
眼科学 | 33篇 |
药学 | 52篇 |
中国医学 | 5篇 |
肿瘤学 | 92篇 |
出版年
2024年 | 3篇 |
2023年 | 19篇 |
2022年 | 36篇 |
2021年 | 79篇 |
2020年 | 28篇 |
2019年 | 65篇 |
2018年 | 71篇 |
2017年 | 33篇 |
2016年 | 36篇 |
2015年 | 31篇 |
2014年 | 49篇 |
2013年 | 58篇 |
2012年 | 118篇 |
2011年 | 74篇 |
2010年 | 35篇 |
2009年 | 20篇 |
2008年 | 38篇 |
2007年 | 35篇 |
2006年 | 32篇 |
2005年 | 25篇 |
2004年 | 21篇 |
2003年 | 8篇 |
2002年 | 16篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 3篇 |
1998年 | 3篇 |
1996年 | 3篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1989年 | 3篇 |
1987年 | 2篇 |
1979年 | 3篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1969年 | 5篇 |
1968年 | 3篇 |
1926年 | 1篇 |
1924年 | 1篇 |
1923年 | 2篇 |
1920年 | 1篇 |
1917年 | 1篇 |
1915年 | 1篇 |
1914年 | 3篇 |
1913年 | 2篇 |
1911年 | 1篇 |
1910年 | 1篇 |
排序方式: 共有1011条查询结果,搜索用时 15 毫秒
81.
82.
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified) 总被引:3,自引:0,他引:3
Maunoury V Savoye G Bourreille A Bouhnik Y Jarry M Sacher-Huvelin S Ben Soussan E Lerebours E Galmiche JP Colombel JF 《Inflammatory bowel diseases》2007,13(2):152-155
BACKGROUND: Wireless capsule endoscopy (WCE) can identify small bowel mucosal lesions not seen with other imaging modalities. This technique can therefore play an important diagnostic role in the evaluation of patients with inflammatory bowel disease type unclassified (IBDU). We report on a multicentric study whose objective was to evaluate the value of WCE to increase diagnostic accuracy in categorizing IBDU. METHODS: Thirty patients with IBDU and negative serology were included. WCE was performed with a standard Pillcam capsule. Outcome measures were classified as suggestive of Crohn's disease (CD) when -3 ulcerations were present. RESULTS: WCE displayed endoscopic features suggestive for CD in 5 patients. In 6 other patients, WCE was negative, but repeated ileocolonoscopy with biopsies performed during follow-up evaluation revealed CD in 5 and ulcerative colitis (UC) in 1 patient. UC was found in a seventh case at colectomy performed just after WCE. Eighteen patients remained with a diagnosis of IBDU 16 months on average after WCE. CONCLUSIONS: WCE is a potentially clinically useful technique for categorizing a subgroup of patients with IBDU, although negative WCE does not exclude further diagnosis of CD. Patients with negative WCE who remain IBDU at follow-up evaluation may belong to an original subgroup of IBD. 相似文献
83.
Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation 总被引:1,自引:0,他引:1
Cheema A Dong J Dalal D Marine JE Henrikson CA Spragg D Cheng A Nazarian S Bilchick K Sinha S Scherr D Almasry I Halperin H Berger R Calkins H 《Journal of cardiovascular electrophysiology》2007,18(4):387-391
Background: Although it is well recognized that recovery of pulmonary vein (PV) conduction is common among patients who fail atrial fibrillation (AF) ablation, little is known about the precise time course of recurrence.
Objective: To determine the incidence and time course of early recurrence of conduction after PV isolation during AF ablation.
Methods: The patient population was composed of 14 consecutive patients (9 men [64%]; age 56 ± 7 years) with AF who underwent radiofrequency catheter ablation via circumferential ablation with PV isolation, determined by a circular mapping catheter. After successful isolation of the PVs, repeat circular electrode recordings from each PV were obtained at 30 and 60 minutes.
Results: After complete isolation of all PVs, early PV recurrence was observed in 13 (93%) patients and 26 veins (50%). Seventeen veins (33%) showed a first recurrence at 30 minutes, while nine veins (17%) showed a first recurrence at 60 minutes.
Conclusion: The results reveal an extremely high rate of early recurrence of PV conduction following AF ablation. It is particularly notable that about one-fifth of the veins remained isolated at 30 minutes, but subsequently developed recurrence between 30 and 60 minutes. Of the veins that showed early recurrence, one-third developed a first recurrence at 60 minutes. These findings suggest that AF ablation procedures should incorporate a 60-minute waiting period after initial isolation in order to detect early recurrence of conduction. 相似文献
Objective: To determine the incidence and time course of early recurrence of conduction after PV isolation during AF ablation.
Methods: The patient population was composed of 14 consecutive patients (9 men [64%]; age 56 ± 7 years) with AF who underwent radiofrequency catheter ablation via circumferential ablation with PV isolation, determined by a circular mapping catheter. After successful isolation of the PVs, repeat circular electrode recordings from each PV were obtained at 30 and 60 minutes.
Results: After complete isolation of all PVs, early PV recurrence was observed in 13 (93%) patients and 26 veins (50%). Seventeen veins (33%) showed a first recurrence at 30 minutes, while nine veins (17%) showed a first recurrence at 60 minutes.
Conclusion: The results reveal an extremely high rate of early recurrence of PV conduction following AF ablation. It is particularly notable that about one-fifth of the veins remained isolated at 30 minutes, but subsequently developed recurrence between 30 and 60 minutes. Of the veins that showed early recurrence, one-third developed a first recurrence at 60 minutes. These findings suggest that AF ablation procedures should incorporate a 60-minute waiting period after initial isolation in order to detect early recurrence of conduction. 相似文献
84.
85.
86.
87.
Boige V Malka D Elias D Castaing M De Baere T Goere D Dromain C Pocard M Ducreux M 《Annals of surgical oncology》2008,15(1):219-226
Background We have previously shown promising activity of hepatic arterial infusion (HAI) oxaliplatin combined with intravenous (IV)
5-fluorouracil (5-FU) and leucovorin (LV) as first-line chemotherapy in patients with colorectal liver metastases (CRLM) (intent-to-treat
[ITT] objective response rate [ORR], 64%; secondary resection rate, 18%; overall survival [OS], 27 months). Whether this regimen
could be beneficial after systemic chemotherapy failure is unknown.
Methods Patients with unresectable CRLM and history of systemic chemotherapy failure were treated bimonthly with HAI oxaliplatin (100
mg/m2 2 hours) combined with IV LV and IV bolus and infusional 5FU (modified LV5FU2 regimen).
Results Forty-four consecutive patients (median age 56 years; median number of prior systemic chemotherapy regimens, 2 range 1–5)
were included, of whom 43 (98%) had previously received oxaliplatin (n = 34), irinotecan (n = 37), or both (n = 28). Patients received a median of nine cycles of HAI oxaliplatin and IV modified LV5FU2 (range 0–25). Toxicity included
grade 3–4 neutropenia (43%), grade 2–3 neuropathy (43%), and grade 3–4 abdominal pain (14%). We observed 24 partial ORs (62%)
among the 39 assessable patients (ITT ORR, 55%; 95% CI, 40–69%), including 17, 12, and 12 patients who had failed to respond
to prior systemic chemotherapy with FOLFIRI, FOLFOX, or both, respectively. Tumor response allowed further R0 surgical resection
(n = 7) or radiofrequency ablation (n = 1) of initially unresectable CRLM in eight patients (18%). Median progression-free survival and OS were 7 and 16 months,
respectively.
Conclusions HAI oxaliplatin and IV LV5FU2 is feasible, safe, and shows promising activity after systemic chemotherapy failure, allowing
surgical resection of initially unresectable CRLM in 18% of patients. 相似文献
88.
89.
90.